ATON

AlphaTON Capital

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 93.3%
Negative

Neutral
GlobeNewsWire
9 hours ago
AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025
Washington, DC, Oct. 27, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital (NASDAQ: ATON) is proud to announce that Brittany Kaiser, CEO, will be a featured speaker at the Future of Money, Governance, and the Law (FoMGL) summit, taking place on Capitol Hill on October 30, 2025.
AlphaTON Capital CEO Brittany Kaiser to Speak at “Future of Money, Governance, and the Law” Summit on Capitol Hill, October 30, 2025
Neutral
GlobeNewsWire
2 days ago
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4's Path to First- Patient Dosing
Poster presented today in Boston shows direct anti-tumor activity in mesothelioma models, reduced tumor PD-L1 alongside decreased pCREB, and strong TT-4 monotherapy activity with added benefit in anti-PD-1 combinations; TT-4 remains on track for Q1 2026 first-patient dosing Poster presented today in Boston shows direct anti-tumor activity in mesothelioma models, reduced tumor PD-L1 alongside decreased pCREB, and strong TT-4 monotherapy activity with added benefit in anti-PD-1 combinations; TT-4 remains on track for Q1 2026 first-patient dosing
AlphaTON Capital and Cyncado Therapeutics Share New Mesothelioma Data Supporting TT-4's Path to First- Patient Dosing
Neutral
GlobeNewsWire
5 days ago
AlphaTON Capital Joins Blockchain Game Alliance (BGA)
Move Deepens Telegram/TON Gaming Strategy Following Intent to Acquire 51% of GAMEE Move Deepens Telegram/TON Gaming Strategy Following Intent to Acquire 51% of GAMEE
AlphaTON Capital Joins Blockchain Game Alliance (BGA)
Neutral
GlobeNewsWire
5 days ago
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
Abstract published today reports reduced adenosine-mediated PD-L1 in a human epithelioid mesothelioma cell line linked to decreased CREB phosphorylation (pCREB). In vivo, TT-4 monotherapy outperformed anti-PD-1 and the combination was superior to either agent alone. Additional data will be presented with the poster on Saturday, October 25 Abstract published today reports reduced adenosine-mediated PD-L1 in a human epithelioid mesothelioma cell line linked to decreased CREB phosphorylation (pCREB). In vivo, TT-4 monotherapy outperformed anti-PD-1 and the combination was superior to either agent alone. Additional data will be presented with the poster on Saturday, October 25
AACR Abstract: First Evidence that Selective A2B Receptor Inhibition Lowers PD-L1 Tumor Expression and also Directly Suppresses Mesothelioma Tumor Growth
Neutral
GlobeNewsWire
7 days ago
Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican's 10th Anniversary World Changers Summit
Vatican City, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Enzo Villani, Chief Investment Officer of AlphaTON Capital ( NASDAQ: ATON ), has been invited to speak at the 10th Anniversary of the IASC World Changers Summit, held at the historic Casina Pio IV within Vatican City, home of the Pontifical Academy of Sciences. This prestigious gathering brings together global thought leaders, scientists, philosophers, innovators, and humanitarians dedicated to advancing ethics, innovation, and unity across disciplines and nations.
Enzo Villani, Chief Investment Officer of AlphaTON Capital, to Speak at the Vatican's 10th Anniversary World Changers Summit
Neutral
GlobeNewsWire
12 days ago
AlphaTON Capital Powers TOKEN2049 “Origins” Hackathon in Singapore
Awards $25,000 Prize Pool to Global TON Builders Across AI, Payments, and Infrastructure Awards $25,000 Prize Pool to Global TON Builders Across AI, Payments, and Infrastructure
AlphaTON Capital Powers TOKEN2049 “Origins” Hackathon in Singapore
Positive
Schwab Network
12 days ago
How AlphaTON (ATON) is Funding Cancer Research Through Tokenization
Anthony Scaramucci and Brittany Kaiser explain how AlphaTON are using digital assets to fund cancer research and launch companies within blockchain and the “Telegram ecosystem.” AlphaTON (ATON) owns multiple molecules and is looking for “innovative ways” to combine their biotech knowledge with financial systems expertise.
How AlphaTON (ATON) is Funding Cancer Research Through Tokenization
Neutral
GlobeNewsWire
13 days ago
AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network's Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
Dover, DE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) today announced that its CEO, Brittany Kaiser, will appear alongside Anthony Scaramucci, Founder of SkyBridge Capital and SALT, on Schwab Network's Trading 360 with Marley Kayden on Tuesday, October 14 at 11:30 a.m. ET.
AlphaTON Capital CEO Brittany Kaiser and SkyBridge Capital Founder Anthony Scaramucci Join Schwab Network's Trading 360 to Discuss Crypto Innovation and Cancer Research Funding
Neutral
GlobeNewsWire
14 days ago
AlphaTON Capital Launches AI Vertical with MorpheusAI to Accelerate Agentic AI Development on TON and Telegram
Landmark Strategic Partnership Establishes Morpheus as Preferred AI Infrastructure Provider for AlphaTON's Portfolio Companies Landmark Strategic Partnership Establishes Morpheus as Preferred AI Infrastructure Provider for AlphaTON's Portfolio Companies
AlphaTON Capital Launches AI Vertical with MorpheusAI to Accelerate Agentic AI Development on TON and Telegram
Neutral
GlobeNewsWire
14 days ago
Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON
Dover, DE, Oct. 12, 2025 (GLOBE NEWSWIRE) -- AlphaTON Capital Corp. (Nasdaq: ATON) stated that during the market conditions of the past week, AlphaTON Capital is still expanding its TON Treasury, purchasing an additional 300,000 TON off the open market today, adding to the 1.1million TON purchased off the open market last week. With zero liquidations and the majority of its TON assets unencumbered, AlphaTON Capital maintains a debt-to-equity ratio of 0.07. “AlphaTON Capital is continuing to grow its market share in TON while maintaining prudent asset management policies in volatile market conditions.” Enzo Villani, Chief Investment Officer, stated, “Volatility in the markets has been a reality across all trading exchanges since the beginning of market systems. Our team is focused on managing risk and maintaining proper leverage ratios that mitigate the risk in volatility and protect our treasury. We will continue to be prudent in our risk management while capitalizing on growth opportunities in the growing TON ecosystem.”
Market Alert: AlphaTON Capital Continues in Growth Mode and Purchases an additional 300,000 TON